3-Bromomethylphenidate (3-Br-MPH) is a compound from the
phenidate
This is a list of methylphenidate (MPH or MPD) Analog (chemistry), analogues, or Phenidates. The most well known compound from this family, methylphenidate, is widely prescribed around the world for the treatment of attention deficit hyperactivit ...
family, which has reportedly been sold as a
designer drug
A designer drug is a structural or functional analog of a controlled substance that has been designed to mimic the pharmacological effects of the original drug, while avoiding classification as illegal and/or detection in standard drug tests. ...
. It showed the most potent binding to the
dopamine transporter
The dopamine transporter (DAT, also sodium-dependent dopamine transporter) is a membrane-spanning protein coded for in humans by the ''SLC6A3'' gene (also known as ''DAT1''), that pumps the neurotransmitter dopamine out of the synaptic cleft ba ...
of a series of ring-substituted methylphenidate derivatives, and produced
stimulant
Stimulants (also known as central nervous system stimulants, or psychostimulants, or colloquially as uppers) are a class of drugs that increase alertness. They are used for various purposes, such as enhancing attention, motivation, cognition, ...
effects in animal studies.
See also
*
3,4-Dichloromethylphenidate
3,4-dichloromethylphenidate (abbreviated as 3,4-DCMP, and incorrectly as 3,4-CTMP for the d,l-threo diastereomer) is a potent stimulant drug from the List of methylphenidate analogues, phenidate class closely related to methylphenidate. It acts ...
*
4-Fluoromethylphenidate
*
4-Methylmethylphenidate
*
Methylnaphthidate
HDMP-28 or methylnaphthidate is a stimulant drug of the piperidine and naphthylaminopropane groups, closely related to methylphenidate (Ritalin), but with the benzene ring replaced by naphthalene. It is a potent dopamine reuptake inhibitor, wit ...
*
4B-MAR
4'-Bromo-4-methylaminorex (4B-MAR, 4'-Br-4-MAR) is a designer drug from the substituted aminorex family, first definitively identified in Austria in January 2022. Its pharmacological activity has not been reported, but it is believed to have stim ...
References
2-Benzylpiperidines
Carboxylate esters
Designer drugs
Methyl esters
Norepinephrine–dopamine reuptake inhibitors
Stimulants
2-Piperidinyl compounds
3-Bromophenyl compounds
{{nervous-system-drug-stub